Clinical Trial: Aspirin for the Prevention of Ischemic Complications in Giant Cell Arteritis

U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07908082) titled 'Aspirin for the Prevention of Ischemic Complications in Giant Cell Arteritis' on Oct. 14.

Brief Summary: The ASPIRE-GCA Pilot trial will assess the feasibility of a future randomized controlled trial (RCT) evaluating the efficacy of low-dose ASA in preventing ischemic complications in patients with Giant Cell Arteritis (GCA).

ASPIRE-GCA Pilot builds on extensive preparatory work and the findings from this study will inform key feasibility outcomes, including recruitment rate, study-drug delivery and treatment initiation, medication adherence, participant retention, and completeness of follow-up data.

Study Start Date: Oct., 2027 ...